Literature DB >> 21093300

Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: a functional pathway analysis.

Chang Hyun Kang1, Masaki Anraku, Marcelo Cypel, Masaaki Sato, Jonathan Yeung, Sina A Gharib, Andrew F Pierre, Marc de Perrot, Thomas K Waddell, Mingyao Liu, Shaf Keshavjee.   

Abstract

BACKGROUND: Lung donation after cardiac death (DCD), in contrast to donation after brain death (DBD), is a promising and increasingly common method to help relieve the shortage of donor organs. We aimed to study the differential gene expression profiles in lungs of DCD and DBD patients and interpreted the differences using functional pathway analysis.
METHODS: We performed microarray studies on pre- and post-transplant lung tissues from 7 DCD and 12 matched DBD patients. Gene profiling was performed by Affymetrix human gene U-133 plus 2 GeneChip on 35 lung tissues. Principal Component Analysis (PCA), Significance Analysis of Microarray (SAM) and Hierarchical Clustering were performed to identify gross gene expression features and the lists of significantly regulated genes. We used Gene Set Enrichment Analysis (GSEA) and Ingenuity Pathway Analysis (IPA) to determine functional significance and the genomic network relationship.
RESULTS: Gene expression profiles between DCD and DBD demonstrated a clear distinction by PCA, especially in the pre-transplant period. The gene sets enriched in DBD mapped to innate immunity, intracellular signaling, cytokine interaction, cell communication and apoptosis pathways. The networks produced by IPA showed that pro-inflammatory nodes played major role in pre-transplant DBD networks. However, the number of differentially regulated transcripts or gene sets decreased markedly after transplantation between DBD and DCD.
CONCLUSION: Analysis of gene expression profiles in donor lungs showed significant differences in pathway activation between DBD and DCD lungs. The observation of fewer inflammatory features of DCD donor lungs suggests safe application of lung transplantation in properly preserved DCD donor lungs.
Copyright © 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21093300     DOI: 10.1016/j.healun.2010.09.004

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  11 in total

Review 1.  Critical care of the potential organ donor.

Authors:  Anna J Dare; Adam S Bartlett; John F Fraser
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

Review 2.  Ex-vivo lung perfusion therapies: do they add value to organ donation?

Authors:  Amit Lyengar; Alexis Schiazza; Edward Cantu
Journal:  Curr Opin Organ Transplant       Date:  2022-06-01       Impact factor: 2.269

Review 3.  Donation after circulatory death and lung transplantation.

Authors:  Pedro Augusto Reck Dos Santos; Paulo José Zimermann Teixeira; Daniel Messias de Moraes Neto; Marcelo Cypel
Journal:  J Bras Pneumol       Date:  2022-04-20       Impact factor: 2.800

4.  Lung Biomolecular Profile and Function of Grafts from Donors after Cardiocirculatory Death with Prolonged Donor Warm Ischemia Time.

Authors:  Francesca Gori; Jacopo Fumagalli; Caterina Lonati; Andrea Carlin; Patrizia Leonardi; Osvaldo Biancolilli; Antonello Rossetti; Ilaria Righi; Davide Tosi; Alessandro Palleschi; Lorenzo Rosso; Letizia Corinna Morlacchi; Francesco Blasi; Luigi Vivona; Gaetano Florio; Vittorio Scaravilli; Franco Valenza; Alberto Zanella; Giacomo Grasselli
Journal:  J Clin Med       Date:  2022-05-29       Impact factor: 4.964

5.  Ranking metrics in gene set enrichment analysis: do they matter?

Authors:  Joanna Zyla; Michal Marczyk; January Weiner; Joanna Polanska
Journal:  BMC Bioinformatics       Date:  2017-05-12       Impact factor: 3.169

6.  Exploring the role of sphingolipid machinery during the epithelial to mesenchymal transition program using an integrative approach.

Authors:  Anastasia Meshcheryakova; Martin Svoboda; Ammar Tahir; Harald C Köfeler; Alexander Triebl; Felicitas Mungenast; Georg Heinze; Christopher Gerner; Philip Zimmermann; Markus Jaritz; Diana Mechtcheriakova
Journal:  Oncotarget       Date:  2016-04-19

7.  Overcoming the Limits of Reconditioning: Seventeen Hours of EVLP With Successful Transplantation From Uncontrolled Circulatory Death Donor.

Authors:  Alessandro Palleschi; Lorenzo Rosso; Giulia Maria Ruggeri; Giorgio Alberto Croci; Valeria Rossetti; Giuseppe Citerio; Giacomo Grasselli; Mario Nosotti; Alberto Zanella
Journal:  Transplantation       Date:  2021-12-01       Impact factor: 5.385

8.  Endothelin-Converting Enzyme 1 and Vascular Endothelial Growth Factor as Potential Biomarkers during Ex Vivo Lung Perfusion with Prolonged Hypothermic Lung-Sparing.

Authors:  Claudia Hernández-Jiménez; J Raúl Olmos-Zúñiga; Matilde Baltazares-Lipp; Rogelio Jasso-Victoria; Adrián Polo-Jerez; María Teresa Pérez-López; Luis Florentino Vázquez-Justiniano; Néstor Emmanuel Díaz-Martínez; Miguel Gaxiola-Gaxiola; Laura Romero-Romero; Axel Edmundo Guzmán-Cedillo; Mario Enrique Baltazares-Lipp; Juan Carlos Vázquez-Minero; Luis Horacio Gutiérrez-González; Marcelino Alonso-Gómez; Mariana Silva-Martínez
Journal:  Dis Markers       Date:  2022-02-07       Impact factor: 3.434

9.  Transcriptional analysis identifies potential novel biomarkers associated with successful ex-vivo perfusion of human donor lungs.

Authors:  John Robert Ferdinand; Morvern Isabel Morrison; Anders Andreasson; Catriona Charlton; Alisha Kaur Chhatwal; William Earl Scott; Lee Anthony Borthwick; Menna Ruth Clatworthy; Andrew J Fisher
Journal:  Clin Transplant       Date:  2022-01-10       Impact factor: 3.456

10.  Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer.

Authors:  Chih-Hsi Scott Kuo; Chien-Ying Liu; Stelios Pavlidis; Yu-Lun Lo; Yen-Wen Wang; Chih-Hung Chen; How-Wen Ko; Fu-Tsai Chung; Tin-Yu Lin; Tsai-Yu Wang; Kang-Yun Lee; Yi-Ke Guo; Tzu-Hao Wang; Cheng-Ta Yang
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.